Matches in SemOpenAlex for { <https://semopenalex.org/work/W2017515672> ?p ?o ?g. }
Showing items 1 to 84 of
84
with 100 items per page.
- W2017515672 endingPage "286" @default.
- W2017515672 startingPage "281" @default.
- W2017515672 abstract "La maladie de Best est une dystrophie rétinienne héréditaire de transmission autosomique dominante, pouvant se compliquer rarement par la survenue de néovaisseaux choroïdiens. Nous rapportons le cas d’un jeune patient de neuf ans suivi pour une maladie de Best qui s’est présenté dans notre service en raison d’une baisse d’acuité visuelle au niveau de l’œil droit. L’examen ophtalmologique a mis en évidence la présence d’une néovascularisation choroïdienne. Un traitement par une injection intravitréenne de bevacizumab a été réalisé, ce qui a permis une amélioration de l’acuité visuelle en rapport avec une cicatrisation de la lésion néovasculaire. Ce cas souligne l’intérêt des traitements anti-angiogéniques dans la prise en charge des néovaisseaux choroïdiens compliquant la maladie de Best. Best's disease is an autosomal-dominant macular dystrophy, which might lead to choroidal neovascularization. The case of a 9-year-old boy followed up for a Best's disease is hereby reported. The boy was referred to our service department for a decrease in visual acuity in his right eye. Ophthalmoscopic examination revealed a foveolar vitelliform lesion, complicated by a choroidal neovascularization. The patient received a single intravitreal bevacizumab injection, which led to a complete resolution of intraretinal fluid and a significant reduction in neovascularization size. Visual acuity also improved. This case underlines the efficiency efficacy of intravitreal anti-VEGF therapy for choroidal neovascularization in Best's disease." @default.
- W2017515672 created "2016-06-24" @default.
- W2017515672 creator A5061836464 @default.
- W2017515672 creator A5064730042 @default.
- W2017515672 creator A5081272473 @default.
- W2017515672 creator A5083982156 @default.
- W2017515672 date "2011-05-01" @default.
- W2017515672 modified "2023-09-24" @default.
- W2017515672 title "Traitement par injection intravitréenne de bevacizumab de néovaisseaux choroïdiens compliquant une maladie de Best" @default.
- W2017515672 cites W1994160535 @default.
- W2017515672 cites W2047083844 @default.
- W2017515672 cites W2054241592 @default.
- W2017515672 cites W2078887547 @default.
- W2017515672 cites W2081262749 @default.
- W2017515672 cites W2085712747 @default.
- W2017515672 cites W2124415048 @default.
- W2017515672 cites W2145260658 @default.
- W2017515672 cites W2153891723 @default.
- W2017515672 doi "https://doi.org/10.1016/j.jfo.2010.11.021" @default.
- W2017515672 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/21507509" @default.
- W2017515672 hasPublicationYear "2011" @default.
- W2017515672 type Work @default.
- W2017515672 sameAs 2017515672 @default.
- W2017515672 citedByCount "8" @default.
- W2017515672 countsByYear W20175156722014 @default.
- W2017515672 countsByYear W20175156722015 @default.
- W2017515672 countsByYear W20175156722017 @default.
- W2017515672 countsByYear W20175156722019 @default.
- W2017515672 countsByYear W20175156722022 @default.
- W2017515672 crossrefType "journal-article" @default.
- W2017515672 hasAuthorship W2017515672A5061836464 @default.
- W2017515672 hasAuthorship W2017515672A5064730042 @default.
- W2017515672 hasAuthorship W2017515672A5081272473 @default.
- W2017515672 hasAuthorship W2017515672A5083982156 @default.
- W2017515672 hasConcept C118487528 @default.
- W2017515672 hasConcept C126322002 @default.
- W2017515672 hasConcept C134018914 @default.
- W2017515672 hasConcept C141071460 @default.
- W2017515672 hasConcept C2776148792 @default.
- W2017515672 hasConcept C2776694085 @default.
- W2017515672 hasConcept C2777802072 @default.
- W2017515672 hasConcept C2778257484 @default.
- W2017515672 hasConcept C2778271429 @default.
- W2017515672 hasConcept C2778313320 @default.
- W2017515672 hasConcept C2780394083 @default.
- W2017515672 hasConcept C2781359195 @default.
- W2017515672 hasConcept C555293320 @default.
- W2017515672 hasConcept C71924100 @default.
- W2017515672 hasConceptScore W2017515672C118487528 @default.
- W2017515672 hasConceptScore W2017515672C126322002 @default.
- W2017515672 hasConceptScore W2017515672C134018914 @default.
- W2017515672 hasConceptScore W2017515672C141071460 @default.
- W2017515672 hasConceptScore W2017515672C2776148792 @default.
- W2017515672 hasConceptScore W2017515672C2776694085 @default.
- W2017515672 hasConceptScore W2017515672C2777802072 @default.
- W2017515672 hasConceptScore W2017515672C2778257484 @default.
- W2017515672 hasConceptScore W2017515672C2778271429 @default.
- W2017515672 hasConceptScore W2017515672C2778313320 @default.
- W2017515672 hasConceptScore W2017515672C2780394083 @default.
- W2017515672 hasConceptScore W2017515672C2781359195 @default.
- W2017515672 hasConceptScore W2017515672C555293320 @default.
- W2017515672 hasConceptScore W2017515672C71924100 @default.
- W2017515672 hasIssue "5" @default.
- W2017515672 hasLocation W20175156721 @default.
- W2017515672 hasLocation W20175156722 @default.
- W2017515672 hasOpenAccess W2017515672 @default.
- W2017515672 hasPrimaryLocation W20175156721 @default.
- W2017515672 hasRelatedWork W1993277911 @default.
- W2017515672 hasRelatedWork W2018624934 @default.
- W2017515672 hasRelatedWork W2024548441 @default.
- W2017515672 hasRelatedWork W2039336825 @default.
- W2017515672 hasRelatedWork W2042631328 @default.
- W2017515672 hasRelatedWork W2070237388 @default.
- W2017515672 hasRelatedWork W2233259956 @default.
- W2017515672 hasRelatedWork W2314450208 @default.
- W2017515672 hasRelatedWork W2412914714 @default.
- W2017515672 hasRelatedWork W2682124582 @default.
- W2017515672 hasVolume "34" @default.
- W2017515672 isParatext "false" @default.
- W2017515672 isRetracted "false" @default.
- W2017515672 magId "2017515672" @default.
- W2017515672 workType "article" @default.